InvestorsHub Logo
Followers 163
Posts 3093
Boards Moderated 0
Alias Born 11/03/2014

Re: iclight post# 690063

Thursday, 05/09/2024 2:12:29 PM

Thursday, May 09, 2024 2:12:29 PM

Post# of 698720
No mention, except that Northwest Biotherapeutics (NWBio) licensed the DC Vaccine (ATL-DC / aka DCVax) technology from UCLA decades ago.

As a result, NWBio is the only company / organization / entity in the world, that has the global rights to commercialize DCVax as a treatment for all or most solid tumor cancer patients around the world.

These global rights are protected by 100’s of global patents, and protect DCVax as a monotherapy and in combination with other approved treatments, including: PD-1 inhibitors, PDL-1 inhibitors, CSF-1R inhibitors, etc.:

Bullish
Bullish

This is a PSA to all manipulative and collusive Market Makers, Hedge Funds and Short Sellers:

TIME IS RUNNING OUT. THE CLOCK IS TICKING!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News